ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 115 filers reported holding ADMA BIOLOGICS INC in Q2 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $29,000 | +20.8% | 12,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $24,000 | +9.1% | 12,000 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $22,000 | +29.4% | 12,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $17,000 | +21.4% | 12,000 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $14,000 | -26.3% | 12,000 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $19,000 | -74.3% | 12,000 | -71.4% | 0.00% | -50.0% |
| Q1 2021 | $74,000 | -89.9% | 42,000 | -88.8% | 0.00% | -94.6% |
| Q4 2020 | $734,000 | -14.2% | 376,319 | +161.8% | 0.04% | -17.8% |
| Q2 2016 | $855,000 | -12.7% | 143,769 | +18.8% | 0.04% | -26.2% |
| Q1 2016 | $979,000 | -0.4% | 120,976 | -0.6% | 0.06% | -39.6% |
| Q4 2015 | $983,000 | -3.4% | 121,756 | 0.0% | 0.10% | +16.1% |
| Q3 2015 | $1,018,000 | -10.5% | 121,756 | -0.9% | 0.09% | +26.1% |
| Q2 2015 | $1,138,000 | -4.3% | 122,856 | +1.3% | 0.07% | -6.8% |
| Q1 2015 | $1,189,000 | – | 121,300 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital LLC | 3,608,171 | $8,624,000 | 2.44% |
| Broadfin Capital, LLC | 4,226,077 | $10,100,000 | 1.33% |
| MORGENS WATERFALL VINTIADIS & CO INC | 400,000 | $956,000 | 0.85% |
| Consonance Capital Management LP | 4,588,352 | $10,966,000 | 0.81% |
| Perceptive Advisors | 6,521,102 | $14,542,000 | 0.55% |
| Diag Capital Management, LP | 182,100 | $435,000 | 0.50% |
| 683 Capital Management, LLC | 805,000 | $1,924,000 | 0.12% |
| ARDSLEY ADVISORY PARTNERS LP | 50,000 | $120,000 | 0.03% |
| AVANTAX ADVISORY SERVICES, INC. | 65,050 | $156,000 | 0.03% |
| PURA VIDA INVESTMENTS, LLC | 37,170 | $89,000 | 0.02% |